THE SHARE: Change: -0.03 SEK (-3.90%) / Price: 0.74 SEK / Mar 20, 2023, 4:33 pm (CET)
  • Home
  • About
    • Introduction
    • Board of Directors
    • Management Team
    • Medical Advisors
    • Corporate Governance
    • Career
  • Technology
    • Physiological Targeting
    • Functional Nanoparticles
    • Publications
    • Patent
  • Portfolio
    • Pipeline
    • SpagoPix
    • Tumorad
  • Investor Relations
    • The Share
    • Analyst Coverage
    • Owners
    • Financial Reports
    • Financial Calendar
    • Equity research
    • Shareholder’s Personal Data
    • Share Issue
  • Media
    • Spago Nanomedical in media
    • Press Releases
    • Subscribe
    • Presentations
    • Events
    • Image Bank
  • Contact
    • Contact us

General meeting

  • 16 Oct, 2019
    Kallelse till extra bolagsstämma i Spago Nanomedical AB (publ)
  • 8 May, 2019
    Eugen Steiner ny ordförande
  • 2 Apr, 2019
    Kallelse till årsstämma i Spago Nanomedical AB (publ)
  • 17 May, 2018
    Kommuniké från årsstämma 2018 i Spago Nanomedical AB (publ)
  • 11 Apr, 2018
    Kallelse till årsstämma i Spago Nanomedical AB (publ)
  • 22 Sep, 2017
    Kommuniké från bolagsstämma i Spago Nanomedical AB (publ)
  • 22 Aug, 2017
    Kallelse till extra bolagsstämma i Spago Nanomedical AB (publ)
  • 18 May, 2017
    Kommuniké från årsstämma i Spago Nanomedical AB
  • 11 Apr, 2017
    Kallelse till årsstämma i Spago Nanomedical AB (publ)
  • 12 May, 2016
    Kommuniké från årsstämma i Spago Nanomedical AB
  • 1
  • 2
  • 3
  • Previous
  • Next
Back

About Spago Nanomedical

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of life-threatening and debilitating diseases.

Address

Spago Nanomedical AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

Phone: +46 46 811 88
LinkedIn

Member of:

Copyright © 2023 Spago Nanomedical AB. All Rights Reserved.
Design by Clavis Communications